Verana Health

Verana Health, formerly DigiSight, is a digital health company committed to delivering quality drug lifecycle and medical practice insights from an exclusive real-world data network.

Verana Health is assembling the largest clinical databases in medicine to empower physicians and accelerate research for patients.

Verana Health was founded in 2018. The company is headquartered in San Francisco, California, with offices in New York and Knoxville, Tennessee.

 

Verana Health has two core products — the VeraQ platform, which is pitched as a health data engine that connects disparate, unfiltered healthcare data; and Qdata, which are data sets derived from VeraQ for diseases including ophthalmology, neurology, and urology.

 

The Verana Health platform uses natural language processing (NLP) and machine learning to “preserve the integrity of the original clinical context” of a healthcare provider’s notes and inputs — essentially, making sense of unstructured text data in electronic health records (EHRs).

 

Verana is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology and collaborates with multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies.

 

Verana Health is backed by GV, JJDC, Novo Holdings, Casdin Capital, erck Global Health Innovation Fund, THVC, Breyer Capital, and others. The company raised $150M in Series E round on Jan 14, 2022. This brings Verana Health's total funding to $288.8M to date.

 

 

  • Year founded: 2018
  • Funding Info: $288.8M over 5 Rounds (Latest Funding Type: Series E)
  • Yearly Revenue: NA
  • Employee Size: 201-500
  • Business Valuation: NA
  • City/Town: San Francisco
  • State: California
  • Country: United States
Related businesses